Current status of antidysrhythmic drugs.
D000109:Acetylcholine / Q000627:therapeutic use; D000136:Acid-Base Equilibrium; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002395:Catecholamines / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors; D004554:Electric Countershock; D004573:Electrolytes / Q000378:metabolism; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D010101:Oxygen Consumption; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use
D002301:Cardiac Glycosides; D002395:Catecholamines; D002800:Cholinesterase Inhibitors; D004573:Electrolytes; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide; D000109:Acetylcholine